Photobiomodulation Market

Photobiomodulation Market Size and Forecast

The global Photobiomodulation Market is valued at USD 249.5 Million in 2024 and is projected to reach a value of USD 514.5 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 6.8% between 2025 and 2035.

Photobiomodulation Market Key Highlights

• Based on the Application, the pain management category accounted for significant market share in Photobiomodulation market industry for 41.50% in 2024
• In 2024, by Wavelength, Infrared-Light (NIR) dominated the Photobiomodulation market with 44.70% of market share
• Based on the Device Type, the Low-Level Laser Therapy (LLLT) devices category accounted for significant market share in Photobiomodulation market industry for 44.50% in 2024
• In 2024, by End User, the Hospitals dominated the Photobiomodulation market with largest revenue share
• North America dominated the Photobiomodulation market industry with 36.40% Photobiomodulation market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period in Photobiomodulation market industry

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Photobiomodulation Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant driver of the Photobiomodulation market. Due to increasing aging populations, sedentary lifestyles, and higher rates of obesity, conditions such as musculoskeletal disorders, arthritis, diabetic neuropathy, and chronic back pain are becoming increasingly common. According to National Library of Medicines, Osteoarthritis (OA) is a painful joint disease affecting more than 32.5 million adults in the US and over 350 million adults worldwide. The prevalence is expected to rise continually over the next several decades with significant impacts to societal health and economic costs as well as individuals' daily activities and quality of life. Additionally, the increasing burden of healthcare costs associated with chronic disease management is prompting both patients and practitioners to seek innovative, cost-effective therapies like PBM, further fueling its global adoption of Photobiomodulation market.

Rising Healthcare Expenditure and Aging Population

Increasing life expectancy, so does the prevalence of age-related conditions such as osteoarthritis, chronic pain, neurodegenerative diseases, and slow-healing wounds. According to World health organization, By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Additionally, higher healthcare spending both at the government and consumer levels has led to greater investments in advanced medical technologies, including PBM devices, supporting Photobiomodulation market expansion. The convergence of these factors creates a strong, sustainable growth trajectory for PBM solutions worldwide.

Photobiomodulation Market Opportunity

Technological Innovation in Photobiomodulation Market

The technologically development is the development of more efficient light-emitting diodes (LEDs) and low-level laser technologies.The key innovation is the rise of portable and wearable PBM devices, designed to meet the growing demand for home healthcare solutions. These compact devices allow patients to continue therapy outside clinical settings, promoting convenience and improving treatment adherence. Moreover, multi-wavelength and pulsed light systems have transformed the PBM landscape by expanding its range of therapeutic applications. By incorporating different wavelengths or pulsed light technology, manufacturers have created devices that are effective not only for pain management but also for wound healing, dermatological conditions, and even neurological disorders such as traumatic brain injuries and depression.

Application Insights

The Application segment is divided into Pain Management, Wound Healing, Musculoskeletal Disorders, Arthritis, Dermatology, Nerve Regeneration, Dental Applications, Neurological Disorders, Other Therapeutic Areas. The Pain Management segment held the dominant share in 2024, accounting for significant Photobiomodulation industry share of 41.50%.

Pain Management: This segment held the most market share in 2024 of Photobiomodulation market. The Pain management segment is categorized into Chronic Pain and Acute Pain.

• Chronic Pain: The Photobiomodulation market device is widely used for managing long-term pain conditions, including fibromyalgia, lower back pain, and neuropathic pain. Its ability to reduce inflammation and promote tissue repair makes it a popular alternative to pain medication
• Acute Pain: This includes short-term pain from injuries, surgeries, or dental procedures. PBM accelerates healing and provides immediate pain relief without the side effects of pharmaceuticals

Wound Healing: The Wound Healing segment is categorized into Surgical wounds, Diabetic Ulcers, and Pressure Sores.

• Surgical Wounds: PBM promotes faster healing by enhancing cellular energy production and improving circulation, reducing post-operative complications
• Diabetic Ulcers: Chronic wounds, particularly diabetic foot ulcers, benefit from PBMs ability to stimulate tissue regeneration and angiogenesis
• Pressure Sores: Common in bedridden patients, these wounds heal more effectively with PBM therapy due to its anti-inflammatory and cell-proliferative effects

Musculoskeletal Disorders: The Musculoskeletal Disorders segment is categorized by Tendinitis, Muscle Strains, and Sprains.

• Tendinitis: PBM helps reduce pain and inflammation in tendons, improving mobility and recovery times
• Muscle Strains: Athletes and active individuals use PBM to speed up recovery from muscle injuries by enhancing circulation and reducing soreness
• Sprains: Similar to muscle strains, PBM supports faster healing of ligament injuries by modulating inflammatory responses

Arthritis: The Arthritis segment is divided into Osteoarthritis, Rheumatoid Arthritis.

• Osteoarthritis: PBM provides pain relief and improves joint function by reducing inflammation and stimulating cartilage regeneration
• Rheumatoid Arthritis: In autoimmune arthritis, PBM helps alleviate joint pain and stiffness while modulating immune system activity

Dermatology: The Dermatology segment is categorized into Acne Treatment, Skin Rejuvenation, and Psoriasis and Eczema.

• Acne Treatment: PBM reduces acne inflammation and bacteria, improving skin clarity and texture
• Skin Rejuvenation: Used for anti-aging, PBM stimulates collagen production and enhances skin elasticity
• Psoriasis and Eczema: By reducing inflammation and promoting healthy skin cell turnover, PBM offers a drug-free treatment option for these chronic skin conditions

Nerve Regeneration: The Nerve Regeneration segment is categorized into Peripheral Neuropathy, and Nerve Injury Recovery.

• Peripheral Neuropathy: PBM is effective in alleviating nerve pain and promoting the regeneration of damaged peripheral nerves
• Nerve Injury Recovery: After trauma or surgery, PBM aids in faster nerve healing and functional recovery

Dental Applications: The Dental Application segment is categorized into Periodontal Therapy, and Oral Mucositis.

• Periodontal Therapy: PBM supports gum health by reducing inflammation and enhancing tissue regeneration in periodontal disease treatment
• Oral Mucositis: A common side effect of cancer treatment, oral mucositis symptoms are alleviated through PBMs anti-inflammatory and healing properties

Neurological Disorders: The Neurological Disorders segment is divided into Traumatic Brain injury (TBI), and Stroke Recovery.

• Traumatic Brain Injury (TBI): PBM is gaining attention for its neuroprotective and cognitive-enhancing effects in TBI recovery.
• Stroke Recovery: By improving cerebral blood flow and reducing inflammation, PBM aids in neurological recovery post-stroke.

Device Type Insights

The Device Type segment is divided into Low-Level Laser Therapy (LLLT) Devices, Light Emitting Diode (LED) Devices, Full-Body Photobiomodulation Chambers, Combination Therapy Devices, Wearable Devices. The Low-Level Laser Therapy (LLLT) Devices segment held the dominant share in 2024, accounting for significant Photobiomodulation industry share of 44.50%.

• Low-Level Laser Therapy (LLLT) Devices: This segment held the most market share in 2024 of Photobiomodulation market. These devices use low-intensity lasers to penetrate tissues, stimulating cellular function and promoting healing. They are commonly used for pain management, wound healing, and musculoskeletal treatments, offering precise and effective therapy
• Light Emitting Diode (LED) Devices: LED-based PBM devices offer a more affordable and versatile alternative to laser systems. They are widely adopted in dermatology and home healthcare, providing safe, non-invasive treatment for skin rejuvenation, acne, and pain relief
• Full-Body Photobiomodulation Chambers: These advanced chambers provide whole-body therapy, delivering consistent wavelengths of light to promote systemic healing, reduce inflammation, and improve overall wellness. They are gaining traction in sports recovery and wellness clinics
• Combination Therapy Devices: Combining multiple light wavelengths and therapeutic modalities, these devices offer comprehensive treatment options for complex conditions such as chronic pain and neurological disorders, enhancing clinical outcomes
• Wearable Devices: Wearable PBM devices are designed for convenience and continuous therapy, allowing users to receive treatment while going about their daily routines. These innovative solutions are particularly popular for managing chronic pain, sports injuries, and dermatological care

End User Insights

The End User segment is divided into Hospitals, Clinics, Home care settings, Research Institutes, Others. The Hospitals segment held the dominant share in 2024, accounting for significant Photobiomodulation industry share.

• Hospitals: This segment held the most market share in 2024 of Photobiomodulation market, as they offer advanced treatment options and have access to cutting-edge medical technologies. PBM devices in hospitals are often used for pain management, wound healing, and post-surgical recovery. The presence of specialized healthcare professionals and infrastructure ensures accurate diagnosis and effective application, boosting the adoption of PBM therapies in inpatient and outpatient care
• Clinics: Clinics, including specialized pain management and physiotherapy centers, are key contributors to the Photobiomodulation market. These settings provide targeted treatments for musculoskeletal conditions, sports injuries, and chronic pain, often offering more personalized and cost-effective alternatives to hospital care. The convenience and accessibility of clinics make them popular among patients seeking non-invasive therapeutic solutions
• Home Care Settings: The home care segment is witnessing significant growth in Photobiomodulation market, driven by the increasing availability of portable and easy-to-use PBM devices. Patients with chronic pain, arthritis, or slow-healing wounds benefit from the convenience of at-home treatments, reducing the need for frequent visits to healthcare facilities. This segment is expected to expand further as technology advances and consumer awareness about self-care options increases

Photobiomodulation Market Regional Trends

In 2024, the North America captured 36.40% of the revenue share.

North America Photobiomodulation Market Trends

North America Photobiomodulation Market is driven by rising healthcare costs, increasing prevalence of chronic disease, rising aging population, and technological advancement. Additionally, strong presence of market players, favorable reimbursement policies, increasing awareness about PBM Therapies. The North America is home to many innovators and early adopters of photobiomodulation therapies.

U.S. Photobiomodulation Market Trends

U.S. Photobiomodulation Market is driven by technological advancements and a strong focus on research and development, contributing to the adoption of PBM devices across various healthcare settings. The increasing acceptance of non-invasive therapies among both healthcare providers and patients further propels Photobiomodulation market industry expansion. As a result, the U.S. continues to lead the Photobiomodulation market, with expectations of sustained growth in the coming years.

Asia Pacific Photobiomodulation Market Trends

Asia Pacific is the fastest growing region for Photobiomodulation market. The market is experiencing rapid growth, driven by factors such as rising medical tourism, fast economic development, and improving access to healthcare in countries like China and India. Governments in the region are increasingly focusing on improving access to advanced healthcare through strategic policy reforms, encouraging the widespread adoption of photobiomodulation across applications such as wound healing and pain management.

Japan Photobiomodulation Market Trends

Japan Photobiomodulation Market is driven by the countrys advanced technological landscape and substantial investments in medical research. As the Japanese population continues to age, there is an increasing demand for effective, non-invasive treatments for chronic pain and related conditions.

Australia Photobiomodulation Market Trends

Australia Photobiomodulation Market is driven by rising prevalence of arthritis has positioned Australia as a leader in healthcare markets related to these conditions. According to Australian Bureau of statistics, In December 2023, Just under 3.7 million people (14.5%) had arthritis in 2022, and this has remained steady since 2004–05 (15.3%). Additionally, older adults aged 75 years and over were more likely than any other age group to have arthritis, with almost one in two (48.9%) having arthritis in 2022.

Photobiomodulation Market Trends

1. Rising Adoption in Pain Management and Rehabilitation: One of the most significant drivers for the Photobiomodulation market is its growing use in non-invasive pain management and physical rehabilitation. As awareness increases about PBM’s efficacy in reducing inflammation, accelerating tissue repair, and managing chronic pain conditions, healthcare providers and patients are increasingly turning to this therapy as an alternative to pharmaceuticals
2. Expansion of Home-Use Devices: The Photobiomodulation market is witnessing a surge in the demand for portable, easy-to-use PBM devices designed for home care settings. This trend is fueled by the aging population, rising prevalence of chronic diseases, and the preference for convenient, cost-effective self-care solutions. Advances in technology, such as wearable PBM devices, are further driving this segment
3. Technological Advancements and Product Innovation: Ongoing R&D efforts are leading to more efficient, compact, and versatile PBM devices. Innovations such as multi-wavelength lasers, smart PBM systems with mobile app connectivity, and customizable treatment protocols are enhancing clinical outcomes and boosting market penetration across different therapeutic areas

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Competitive Landscape

The Photobiomodulation market report is characterized by the presence of both established players and emerging companies, each strive for market share through product innovation, strategic partnerships, and geographic expansion. The Photobiomodulation market is characterized by intense competition as companies strive to innovate, expand their product portfolios, and capture a larger share of the growing demand for photobiomodulation. Companies offering flexible, multi-application PBM devices (for musculoskeletal pain, dermatology, and neurological disorders) are gaining a competitive edge.

The key players in the global Photobiomodulation market include - ALCON Inc among others.

Latest Announcements

LumiThera Announces First CPT Code to Report Photobiomodulation Therapy in Retinal Disease – First Step Toward Reimbursement

• In August 2024, LumiThera Inc., a medical device company commercializing a photobiomodulation (PBM) treatment for ocular damage and disease, today announced a new Category III CPT code effective January 1, 2025. The AMA’s CPT Editorial Panel considered and approved the company’s application for a code to report “Photobiomodulation therapy of retina, single session” at the May 2024

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

• In January 2024, Iridex Corporation, a global leader in innovative laser-based medical systems for the treatment of eye diseases, proudly announces the US launch of its next- generation platform Iridex 532® and Iridex 577® Lasers alongside its 35th anniversary celebration

Photobiomodulation Market Segments Covered in the report:

By Application:

• Pain Management
  • Chronic Pain
  • Acute Pain
• Wound Healing
  • Surgical Wounds
  • Diabetic Ulcers
  • Pressure Sores
• Musculoskeletal Disorders
  • Tendinitis
  • Muscle Strains
  • Sprains
• Arthritis
  • Osteoarthritis
  • Rheumatoid Arthritis
• Dermatology
  • Acne Treatment
  • Skin Rejuvenation
  • Psoriasis and Eczema
• Nerve Regeneration
  • Peripheral Neuropathy
  • Nerve Injury Recovery
• Dental Applications
  • Periodontal Therapy
  • Oral Mucositis
• Neurological Disorders
  • Traumatic Brain Injury (TBI)
  • Stroke Recovery
• Other Therapeutic Areas

By Wavelength:

• Infrared Light (NIR)
  • 800-900 nm
  • 900-1000 nm
• Red Light
  • 600-700 nm
  • 700-800 nm
• Others

By Device Type:

• Low-Level Laser Therapy (LLLT) Devices
  • Single-Wavelength Lasers
  • Multi-Wavelength Lasers
• Light Emitting Diode (LED) Devices
  • Portable Devices
  • Tabletop Devices
• Full-Body Photobiomodulation Chambers
• Combination Therapy Devices
• Wearable Devices

By End User:

• Hospitals
• Clinics
• Home care settings
• Research Institutes
• Others

Photobiomodulation Market Regions and Countries:

North America

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Nordic Countries
• Benelux Union
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America

The Middle-East and Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of Middle-East Africa